CHRISTOPHER P. LOWE
CIK 1376260 · Interim CEO, COO & CFO · last filed 2022-08-26
CHRISTOPHER P. LOWE is an Interim CEO, COO & CFO who has filed 47 SEC Form 4 insider transactions across 5 companies since 2007. The most recent filing shows the insider bought $49.4K of VINC on Aug 26, 2022. Across all open-market trades the lifetime net is −$3.8M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $508 across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$508
5
47
-$3.81M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| VINC | Director | 40,000 | $0.01 | $508 | $175.6K | 4 | 2022-08-26 |
| Quince Therapeutics, Inc. (CRTX) Delisted | Interim CEO, COO & CFO | 265,000 | $1.95 | $516.8K | -$3.67M | 10 | 2022-03-04 |
| Vincerx Pharma, Inc. (VINCW) Delisted | Director | — | $1.61 | — | $0 | 1 | 2020-12-28 |
| HANSEN MEDICAL INC (HNSN) Delisted | Interim CFO | 22,500 | — | — | $45.6K | 12 | 2016-02-04 |
| Anthera Pharmaceuticals Inc (ANTH) Delisted | CFO and Chief Business Officer | 108,915 | — | — | -$367.0K | 19 | 2013-05-21 |
Recent Filings
47 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-08-26 | VINC | Buy (P) | +30,000 | $49.4K | EDGAR |
| 2022-05-31 | VINC | Grant (A) | — | $0 | EDGAR |
| 2022-03-04 | Quince Therapeutics, Inc. (CRTX) Delisted | Grant (A) | +175,000 | $0 | EDGAR |
| 2022-01-05 | Quince Therapeutics, Inc. (CRTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-11-16 | Quince Therapeutics, Inc. (CRTX) Delisted | Exer (M) | +30,000 | $66.9K | EDGAR |
| 2021-10-07 | Quince Therapeutics, Inc. (CRTX) Delisted | Mixed | — | -$216.6K | EDGAR |
| 2021-08-18 | Quince Therapeutics, Inc. (CRTX) Delisted | Mixed | +30,000 | -$1.98M | EDGAR |
| 2021-06-30 | Quince Therapeutics, Inc. (CRTX) Delisted | Mixed | +30,000 | -$971.6K | EDGAR |
| 2021-06-30 | VINC | Buy (P) | +10,000 | $126.2K | EDGAR |
| 2021-05-14 | VINC | Grant (A) | — | $0 | EDGAR |